Amneal Pharmaceuticals, Inc. (AMRX)

12.68 -0.20 (-1.55%) USD  |  NASDAQ  |  Dec 31, 11:32
More

Amneal Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Amgen, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
United Therapeutics Corp. Upgrade
Xeris Biopharma Holdings, Inc. Upgrade